Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Taburet

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|May 1, 1996
Drug interactions with antiviral drugsA M Taburet, E Singlas
Clinical Pharmacokinetics|May 1, 1994
Pharmacokinetic optimisation of asthma treatmentA M Taburet, B Schmit
Therapie|July 31, 2001
[Drug interactions with antiretroviral agents]V Furlan, A M Taburet
Biochemical Pharmacology|December 15, 1983
Valproate glucuronidation by rat liver microsomes. Interaction with parahydroxyphenobarbitalA M Taburet, P Aymard
Fundamental & Clinical Pharmacology|April 11, 2003
In vitro effects of tacrolimus on human cytochrome P450K Lecointre, V Furlan, A M Taburet
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1985
[Clinical pharmacology of calcium inhibitors]E Singlas, H Martre, A M Taburet
Clinical Pharmacokinetics|December 1, 1990
The effect of respiratory disorders on clinical pharmacokinetic variablesA M Taburet, C Tollier, C Richard
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomesB Baune, V Furlan, A M Taburet, et al.
Pediatric Transplantation|August 10, 2000
Conversion from cyclosporin A to tacrolimus in pediatric liver transplantationV Furlan, D Debray, C Fourre, et al.
Journal of Clinical Pharmacy and Therapeutics|June 1, 1991
Pharmacokinetics of tobramycin in pregnant women. Safety and efficacy of a once-daily dose regimenP Bourget, H Fernandez, C Delouis, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|May 1, 1996
Drug interactions with antiviral drugsA M Taburet, E Singlas
Clinical Pharmacokinetics|May 1, 1994
Pharmacokinetic optimisation of asthma treatmentA M Taburet, B Schmit
Therapie|July 31, 2001
[Drug interactions with antiretroviral agents]V Furlan, A M Taburet
Biochemical Pharmacology|December 15, 1983
Valproate glucuronidation by rat liver microsomes. Interaction with parahydroxyphenobarbitalA M Taburet, P Aymard
Fundamental & Clinical Pharmacology|April 11, 2003
In vitro effects of tacrolimus on human cytochrome P450K Lecointre, V Furlan, A M Taburet
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1985
[Clinical pharmacology of calcium inhibitors]E Singlas, H Martre, A M Taburet
Clinical Pharmacokinetics|December 1, 1990
The effect of respiratory disorders on clinical pharmacokinetic variablesA M Taburet, C Tollier, C Richard
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 30, 1999
Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomesB Baune, V Furlan, A M Taburet, et al.
Pediatric Transplantation|August 10, 2000
Conversion from cyclosporin A to tacrolimus in pediatric liver transplantationV Furlan, D Debray, C Fourre, et al.
Journal of Clinical Pharmacy and Therapeutics|June 1, 1991
Pharmacokinetics of tobramycin in pregnant women. Safety and efficacy of a once-daily dose regimenP Bourget, H Fernandez, C Delouis, et al.
Pageof 8